Press

Circle U. Elects its New President

At the General Assembly held on November 18th 2022 at Université Paris Cité, Vincent Blondel, Rector of the University of Louvain, was elected as new President of Circle U. Succeeding Svein Stølen, Rector of the University of Oslo, he will steer the strategic...

The 2022 Highly Cited Researchers at Université Paris Cité

With 20 citations, Université Paris Cité is the 2nd French university in the 2022 ranking of Highly Cited Researchers published by Web of Science Group. Do you know the HiCi? Behind this abbreviation lies a highly recognised list of researchers...

Two major meteorite impacts shed light on the interior of Mars

By studying seismic and orbital data from two major meteorite impacts in late 2021, the international teams of NASA's InSight and Mars Reconnaissance Orbiter missions are refining their knowledge of the Martian interior. Two studies published on 27 October in the...

Towards a European evaluation framework for digital medical devices (DMDs) in the European Union – Launch of a European taskforce

The objective of the European taskforce is to reach a mutual understanding between competent agencies with competences in health technology assessment for digital medical devices (DMDs) at national level, in order to harmonise the assessment criteria in the European...

[CLOVES syndrome] : The U.S. FDA approves Alpelisib based on a French study

AP-HP, Inserm and Université Paris Cité extend their congratulations to Professor Guillaume Canaud’s teams at Necker-Enfants Malades Hospital (AP-HP), Necker-Enfants Malades Institute (INEM), Inserm, Institut Imagine and Université Paris Cité for their work on alpelisib (BYL719), approved by the US Food and Drug Administration (FDA).

[SARS-CoV-2] Neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies

The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of...

Initiative of Excellence label confirmed for Université Paris Cité

Further to the international jury’s visit in September 2021, the Prime Minister has announced the permanent labeling of Université Paris Cité as an Initiative of Excellence.

Université Paris Cité, The new name of Université Paris Cité adopted by Decree

Further to an internal and external survey as well as a vote by its governing bodies, Université Paris Cité has become Université Paris Cité. The new name was approved by the Ministry of Higher Education, Research and Innovation, and was adopted by a decree of the...

[VIH] : New Antibody Function Discovered

By applying cutting-edge microscopy techniques to in vitro virus cultures, teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université Paris Cité have discovered a new function of anti-HIV-1[1] antibodies. The scientists found that certain...

Binge-eating: Restoring the Dialogue Between the Gut and the Brain

In a study published on January 24, 2022 in the journal Molecular Psychiatry, the scientific team "Central Control of Eating Behavior and Energy Expenditure" (Functional and Adaptive Biology Unit - Université Paris Cité/CNRS) discovered a new mechaninsm which, by...

Université Paris Cité is to Change its Legal Name

Le ministère de l’Enseignement supérieur, de la Recherche et de l’Innovation (MESRI) et Université Paris Cité prennent acte de la décision d’annulation partielle du décret n°2019-209 sur la dénomination de l’université. Si un travail est d’ores et déjà engagé afin de proposer rapidement aux instances de l’établissement une nouvelle dénomination juridique, ensemble, ils soulignent toute la pertinence et la dynamique d’un projet d’excellence qui porte déjà ses fruits en France et à l’international.

[Covid-19] Omicron : resistant to most monoclonal antibodies but neutralized by a booster dose

Scientists from the Institut Pasteur and the Vaccine Research Institute, in collaboration with KU Leuven (Leuven, Belgium), Orléans Regional Hospital, Hôpital Européen Georges Pompidou (AP-HP), Inserm and the CNRS, studied the sensitivity of the Omicron variant to...

Chronic Alcohol Use : Genetic Variations Provide Protection from Liver Cancer

In a study published on December 10, 2021 in The Lancet Oncology, Prof J. Zucman-Rossi's team at the Cordeliers Research Centre (Université Paris Cité, Sorbonne University, Inserm) and collaborators from the GENTHEP network, identified two new genes; WNT3A-WNT9A,...

Rosetta Mission : Scientists confirm Comet 67P is indeed a binary object!

By analysing the data collected during 2 years by the Rosetta spacecraft, researchers of the Laboratoire d’Etudes Spatiales et d’Instrumentation en Astrophysique (LESIA), find evidences that the periodic comet 67P Churyumov-Gerasimenko is indeed a binary object. © ESA...

The 2021 Highly Cited Researchers at Université Paris Cité

With 17 citations, Université Paris Cité is the 2nd French university in the 2021 ranking of Highly Cited Researchers published by Clarivate, Web of Science Group. Do you know the HiCi? Behind this abbreviation lies a highly recognised list of...

A dramatic drop worldwide in organ transplants since the outbreak of Covid-19

According to a new study published on August 31st, 2021, in Lancet Public Health, covering 22 countries including most of Europe and representing about 70% of global transplant activity, the number of solid organ transplants performed in the first wave of the pandemic...

Parasites and Cancer: A New Epigenetic Approach

Nearly 20% of cancers are associated with microbial infections. While the mechanisms involved are fairly well-known for viruses and bacteria, the role played by parasites remains a mystery. A new study led by Prof. Jonathan Weitzman from the Epigenetics and Cellular...

A world-class partnership in health biology

Christine Clerici, President of Université Paris Cité, and Stewart Cole, Director General of the Institut Pasteur, have formalised the cooperation between their institutions in pursuit of a concerted and shared scientific strategy. The two institutions aim...

The Human Spleen, a cemetery and sanctuary for malaria parasites

Professor Pierre Buffet's research unit (UMRS 1134, Inserm Université Paris Cité), in close collaboration with the team of Professor Chrétien at Institut Pasteur, and an Australian-Indonesian team led by Professor Nick Anstey, observed in patients with...

Covid-19 : Discovery of the mechanisms of short-and long-term anosmia

Loss of smell, or anosmia, is one of the earliest and most commonly reported symptoms of COVID-19. But the mechanisms involved had yet to be clarified. Scientists from the Institut Pasteur, the CNRS, Inserm, Université Paris Cité and the Paris Public Hospital Network...

Covid-19 vaccines and thrombosis: What is it all about?

In response to the thrombosis cases that occurred as a consequence of the Covid-19 vaccinations, Prof. David Smadja, professor of hematology at Université Paris Cité, member of the hematology department of the Georges-Pompidou European Hospital...

Press

Press releases